
Hemal Gada MD MBA
Echocardiography, Interventional Cardiology, Nuclear Cardiology, Cardiac Critical Care
Assistant Professor of Medicine, Rutgers Robert Wood Johnson Medical School Interventional Cardiologist, Robert Wood Johnson University Hospital
Join to View Full Profile
1000 N Front StSte 300Wormleysburg, PA 17043
Phone+1 717-731-0101
Fax+1 717-731-8539
Dr. Gada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Interventional Cardiology, 2012 - 2013
- Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 2009 - 2012
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2005 - 2008
- University of Michigan Medical SchoolClass of 2005
Certifications & Licensure
- PA State Medical License 2015 - 2026
- NJ State Medical License 2014 - 2017
- NY State Medical License 2012 - 2017
- ME State Medical License Active through 2014
- OH State Medical License 2009 - 2012
- MO State Medical License 2008 - 2010
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- Thirty Day and One Year Outcomes from the Optimize PRO TAVR Evolut FX Addendum Study.Hemal Gada, Ramzi F Khalil, Stanley J Chetcuti, G Michael Deeb, Kendra J Grubb
JACC. Cardiovascular Interventions. 2025-06-17 - Prevention of Bilateral Coronary Obstruction During Valve-In-Valve TAVR With a Self- Expanding Valve: The BABICORN Procedure.Ahmed Ghoneem, Mubashir Mumtaz, Arun Kanmanthareddy, Hemal Gada
JACC. Case Reports. 2025-06-07 - Global Results From the Optimize PRO Study: Standardized TAVR Technique and Care Pathway.Kendra J Grubb, Hemal Gada, Douglas Fraser, Josep Rodes-Cabau, Tamim M Nazif
Journal of the Society for Cardiovascular Angiography & Interventions. 2025-05-01
Lectures
- Real-World Experience of the LOTUS Edge ValveCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
- The Financial Implications of a TAVR Program: A Primer on Healthcare Economics and ReimbursementCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019
- Echo AlertCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019
- Join now to see all
Press Mentions
- Q&A: Cardiologist and EARLY TAVR Co-Author Questions Study’s ExecutionJune 13th, 2025
- UPMC Heart and Vascular Institute in Central Pa. Pioneers Valve-in-Valve TAVR Procedure with New FDA-Approved DeviceApril 8th, 2025
- Patient-Centric Outcomes Embraced by Global Heart Valve ExpertsJuly 12th, 2024
- Join now to see all
External Links
- RWJUH TAVR Programhttp://www.rwjuh.edu/tavr/tavr-home.aspx
- LinkedInhttps://www.linkedin.com/pub/hemal-gada/94/629/865
- RWJMShttp://umg.rwjms.rutgers.edu/Public/directory/doctor2.asp?doctor=313596968
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: